Valuation: Zenotech Laboratories Limited

Market Cap 2.09B 21.94M 18.79M 17.58M 16.08M 30.34M 30.63M 207M 80.8M 1.05B 82.36M 80.56M 3.49B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.14M 16.39M 15.33M 14.02M 26.47M 26.72M 181M 70.49M 920M 71.85M 70.28M 3.05B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
28/07 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
29/04 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
24/01 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
23/01 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
29/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
31/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day+0.53%
1 week-3.52%
Current month+2.69%
1 month+3.27%
3 months+3.98%
6 months+1.49%
Current year-0.97%
1 week 44.55
Extreme 44.55
47.55
1 month 43
Extreme 43
49.75
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
57.9
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 23/10/2024
Director of Finance/CFO - 06/02/2014
Compliance Officer 46 11/03/2016
Director TitleAgeSince
Director/Board Member 58 08/07/2015
Chairman 67 -
Director/Board Member 42 27/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-3.52%-17.29%-13.99% 29M
-1.06%+4.27%+73.34%+125.12% 1,111B
+0.53%+4.10%+52.35%+65.45% 658B
+0.48%+6.18%+26.21%+81.27% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+5.45%+50.57%+72.33% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+7.09%+29.62%+94.90% 182B
Average +1.08%+3.64%+27.24%+47.53% 379.1B
Weighted average by Cap. +1.04%+4.68%+44.12%+73.07%

Financials

2024 2025
Net sales 368M 3.86M 3.3M 3.09M 2.83M 5.34M 5.39M 36.47M 14.21M 186M 14.49M 14.17M 614M 391M 4.1M 3.51M 3.28M 3M 5.67M 5.72M 38.74M 15.1M 197M 15.39M 15.05M 653M
Net income 82.99M 870K 745K 697K 638K 1.2M 1.21M 8.22M 3.2M 41.83M 3.27M 3.19M 139M 56.13M 588K 504K 471K 431K 814K 821K 5.56M 2.17M 28.3M 2.21M 2.16M 93.68M
Net Debt -197M -2.06M -1.77M -1.65M -1.51M -2.85M -2.88M -19.51M -7.6M -99.25M -7.75M -7.58M -329M -267M -2.8M -2.4M -2.24M -2.05M -3.87M -3.91M -26.46M -10.31M -135M -10.51M -10.28M -446M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
25/08/26 INR 45.74 +0.53% 4,181
24/08/26 INR 45.50 -1.62% 8,781
21/08/26 INR 46.25 +0.96% 5,264
20/08/26 INR 45.81 -1.36% 7,284
19/08/26 INR 46.44 -2.48% 9,149
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock